{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:06:53Z","timestamp":1771045613861,"version":"3.50.1"},"reference-count":10,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J R Army Med Corps"],"accepted":{"date-parts":[[2017,10,31]]},"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Idiopathic sudden sensorineural hearing loss (ISSNHL) is defined as a 30-decibel (dB) loss in hearing over three contiguous frequencies within 3\u2009days. The cause remains unknown, and there is currently no consensus in the literature as to how it is best treated. Conventional treatment in our unit comprises steroids, pentoxyphiline and dextran, with the potential addition of hyperbaric oxygen therapy (HBOT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective randomised trial was performed on all soldiers diagnosed with ISSNHL in our institution from 1 January 2007 to 31 December 2016. Participants were randomly allocated to one of two groups. Group A was treated with conventional treatment plus HBOT. Group B was treated with conventional treatment only. Data collection included age, gender, clinical symptoms, pure-tone audiometry results and treatment outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>60 participants were enrolled (53 male, 7 female) with ages ranging from 18 to 65 years (mean age of 30.3). No significant differences were observed in the baseline characteristics between the two groups, including gender, age, site, associated symptoms, duration of symptoms and severity of hearing loss. Hearing recovery using Siegel\u2019s criteria on days 8 and 13 showed no significant differences between treatment groups. However, the hearing recovery on day 180 was significantly better in those who received the conventional treatment plus HBOT (P&lt;0.05). Additionally, no significant side effects were observed in either group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HBOT plus existing conventional treatment was associated with a better outcome than conventional treatment alone. We would recommend the addition of HBOT is recommended as a first-line treatment modality for all soldiers presenting with ISSNHL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jramc-2017-000872","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T04:47:46Z","timestamp":1518065266000},"page":"69-71","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Does the addition of hyperbaric oxygen therapy to conventional treatment modalities influence the outcome of soldiers with idiopathic sudden sensorineural hearing loss?"],"prefix":"10.1136","volume":"164","author":[{"given":"Tzu-Hang","family":"Chi","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan"},{"name":"Department of Otolaryngology, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R F","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C H","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,2,3]]},"reference":[{"key":"2025081312371819000_164.2.69.1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1288\/00005537-198405000-00014","article-title":"Sudden hearing loss: eight years' experience and suggested prognostic table","volume":"94","author":"Byl","year":"1984","journal-title":"Laryngoscope"},{"key":"2025081312371819000_164.2.69.2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0030-6665(20)32783-3","article-title":"The treatment of idiopathic sudden sensorineural hearing loss","volume":"8","author":"Siegel","year":"1975","journal-title":"Otolaryngol Clin North Am"},{"key":"2025081312371819000_164.2.69.3","unstructured":"Oliver ER , Hashisaki GT . Sudden sensory hearing loss. In Bailey BJ , ed. Head and neck surgery-otolaryngology. 5th\u00a0edn. Philadelphia: Lippincott Williams and Wilkins, 2014:2589\u201396."},{"key":"2025081312371819000_164.2.69.4","first-page":"127","article-title":"Secondary hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss in the subacute and chronic phases","volume":"57","author":"Ohno","year":"2010","journal-title":"J Med Dent Sci"},{"key":"2025081312371819000_164.2.69.5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/iao.2015.1227","article-title":"Recovery of idiopathic sudden sensorineural hearing loss","volume":"11","author":"Edizer","year":"2015","journal-title":"J Int Adv Otol"},{"key":"2025081312371819000_164.2.69.6","first-page":"59","article-title":"Effect of isobaric oxygen versus hyperbaric oxygen on the normal and noise-damaged hypoxic and ischemic guinea pig inner ear","volume":"54","author":"Lamm","year":"1998","journal-title":"Adv Otorhinolaryngol"},{"key":"2025081312371819000_164.2.69.7","first-page":"195","article-title":"Hyperbaric oxygen therapy for the treatment of large vestibular aqueduct syndrome","volume":"28","author":"Furuhashi","year":"2001","journal-title":"Undersea Hyperb Med"},{"key":"2025081312371819000_164.2.69.8","first-page":"119","article-title":"Complications and side effects of hyperbaric oxygen therapy","volume":"71","author":"Plafki","year":"2000","journal-title":"Aviat Space Environ Med"},{"key":"2025081312371819000_164.2.69.9","first-page":"272","article-title":"Does the addition of a second daily session of hyperbaric oxygen therapy to intratympanic steroid influence the outcomes of sudden hearing loss?","volume":"35","author":"Attanasio","year":"2015","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"2025081312371819000_164.2.69.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-007-0272-6"}],"container-title":["Journal of the Royal Army Medical Corps"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jramc-2017-000872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T19:37:23Z","timestamp":1755113843000},"score":1,"resource":{"primary":{"URL":"https:\/\/militaryhealth.bmj.com\/lookup\/doi\/10.1136\/jramc-2017-000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,3]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,5,9]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/jramc-2017-000872"],"URL":"https:\/\/doi.org\/10.1136\/jramc-2017-000872","relation":{},"ISSN":["0035-8665","2052-0468"],"issn-type":[{"value":"0035-8665","type":"print"},{"value":"2052-0468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,3]]}}}